FDA Chief: COVID, Mail Mix-Up Delayed Action On Baby Formula

Newsy

Published

Watch VideoThe head of the Food and Drug Administration said Wednesday that efforts to investigate problems at a baby formula plant linked to the nationwide shortage were slowed by COVID-19, scheduling conflicts and even a missing piece of mail.

FDA Commissioner Robert Califf laid out a series of setbacks in congressional...

Full Article